SAN FRANCISCO--(BUSINESS WIRE)--Ablexis, LLC, a biotechnology company dedicated to developing the AlivaMab Mouse, an innovative platform for discovery of the next generation of breakthrough antibody drugs, announced today the appointment of Jake Bauer as senior director, corporate development and business operations. Reporting to Larry L. Green, Ph.D., chief executive officer of Ablexis, Mr. Bauer will lead development and implementation of the next phase of the company’s corporate strategy and oversee business operations.
